Table 2.
Markers of disease activity.
| Men (N = 50) | Women (N = 50) | p | |
|---|---|---|---|
| Physician assessment | 2 [0-8] | 3 [0-9] | 0.047 |
|
| |||
| VAS pain | 3 [0-8] | 4 [0-9] | N.S |
|
| |||
| Painful joint count | 3 [0-24] | 8 [0-28] | ≤0.001 |
|
| |||
| Swollen joint count | 2 [0-12] | 6 [0-26] | ≤0.001 |
|
| |||
| ESR (mm/h) | 23.2 [1-68] | 33.0 [19-70] | 0.046 |
|
| |||
| CRP (mg/L) | 13.0 [2-57] | 29.4 [1-112] | N.S |
|
| |||
| PHQ-9 | 5 [0-19] | 4 [0-17] | N.S |
|
| |||
| DAS-28 | 2.5 [0, 9-5, 8] | 3.4 [0, 9-7] | 0.011 |
|
| |||
| (i) Remission | 27 (54%) | 19 (38%) | NS |
|
| |||
| (ii) Low activity | 8 (16%) | 6 (12%) | NS |
|
| |||
| (iii) Moderate Activity | 14 (28%) | 13 (26%) | NS |
|
| |||
| (iv) High activity | 1 (2%) | 12 (24%) | ≤0.001 |
|
| |||
| HAQ-DI | 0.37 [0-3] | 1.12 [0-3] | ≤0.001 |
|
| |||
| (i) Functional disability | 6 (12%) | 18 (36%) | 0.005 |
|
| |||
| (ii) Severe disability | 1 (2%) | 11 (22%) | 0.002 |
N.S: nonsignificant.